C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Market Research 2024: BL-8040; GMI-1359; Plerixafor (AMD3100); Balixafortide (POL6326); USL311; Burixafor (GPC-100) - Global Long-term Forecast to 2033
November 07, 2024 07:43 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The C-X-C chemokine...
Graft versus Host Disease (GvHD) Pipeline Insights Report, 2024: Reveals 60+ Companies Engaged in Advancing 65+ Pipeline Drugs
May 28, 2024 06:38 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Graft versus host disease - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth look...
Global Neutropenia Market Competitive Analysis and Forecast Report to 2028, Featuring BeyondSpring Pharmaceuticals, Coherus Biosciences, Myelo Therapeutics and Spectrum Pharmaceuticals
March 15, 2024 05:14 ET
|
Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Global Neutropenia Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's...
Rising Prevalence of Neutropenia-Related Conditions Propels Global Market to 2028
September 01, 2023 08:29 ET
|
Research and Markets
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Neutropenia Market (2023-2028) by Treatment, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis"...
JAK Inhibitors Competitive Landscape 2023: Comprehensive Insights on 40+ Companies and 45+ Drug Profiles
May 08, 2023 06:38 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "JAK inhibitors - Competitive Landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "JAK inhibitors - Competitive landscape,...
Neutropenia Treatment Market Report 2023: Sector to Reach $20.19 Billion by 2028 at a 5.6% CAGR
March 23, 2023 06:48 ET
|
Research and Markets
Dublin, March 23, 2023 (GLOBE NEWSWIRE) -- The "Neutropenia Treatment Market by Treatment, Distribution channel, and Region 2023-2028" report has been added to ResearchAndMarkets.com's offering.The...
Global PEGylated Proteins Market Analysis & Industry Trends Report 2022: A $2.1 Billion Market by 2028 - Focus on Colony-stimulating Factor, Interferons, Recombinant Factor VII, & Erythropoietin
March 22, 2023 10:13 ET
|
Research and Markets
Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Global PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type (Colony-stimulating Factor,...
The Worldwide Neutropenia Industry is Projected to Reach $5.4 Billion by 2027
June 20, 2022 07:28 ET
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Global Neutropenia Market (2022-2027) by Treatment, Distribution Channel, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff...
Global Axial Spondyloarthritis Market Analysis and Forecasts, 2022-2032: Introduction of Novel Products / Increasing Awareness About the Disease / Rising Research and Development Investments
June 16, 2022 04:23 ET
|
Research and Markets
Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Axial Spondyloarthritis Market - A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products, Indication, and Country...
Global Rheumatoid Arthritis (RA) Market Analysis & Drug Forecasts, 2019-2029 - Late-Stage RA Pipeline Holds Promise But Likely Won't Match the Utility of JAK Inhibitors
January 12, 2021 04:08 ET
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. Global revenues...